Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bf9e16a362eb6ffdd77ffb4362323b32c> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bf9e16a362eb6ffdd77ffb4362323b32c hasDbXref "Orphanet:1909" @default.
- Bf9e16a362eb6ffdd77ffb4362323b32c type Axiom @default.
- Bf9e16a362eb6ffdd77ffb4362323b32c annotatedProperty IAO_0000115 @default.
- Bf9e16a362eb6ffdd77ffb4362323b32c annotatedSource MONDO_0016005 @default.
- Bf9e16a362eb6ffdd77ffb4362323b32c annotatedTarget "Indomethacin embryofetopathy refers to the manifestations that may be observed in a fetus or newborn when the mother has taken indomethacin, a potent prostaglandin inhibitor and tocolytic agent that can cross placenta, during pregnancy. Reported adverse fetal/neonatal effects include decreased renal function resulting in oligohydramnios, closure of the ductus arteriosus, and delayed cardiovascular adaptation at birth. These effects are usually transient and reversible. Indomethacin may also be a risk factor for cerebral injury (periventricular leukomalacia) and necrotizing enterocolitisin preterm infants." @default.